Evidence map›Paper›PMID 36727917›Full record

ArticleInternational journal of laboratory hematology2023

Pitfalls in molecular standardization for detection of FLT3-ITD in acute myeloid leukemia.

Juliana B da Costa, Rafaella G Naressi, Jordana Ramires, Danielle T Vianna, Juliana A Teles, Telma F Padilha, Bárbara da C R Monte-Mór, Ilana Zalcberg, Luciana M Gutiyama

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in International journal of laboratory hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Juliana B da CostaCentro de Transplante de Medula Óssea, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Rafaella G NaressiCentro de Transplante de Medula Óssea, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Jordana RamiresCentro de Transplante de Medula Óssea, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Danielle T ViannaCentro de Transplante de Medula Óssea, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Juliana A TelesDepartamento de Hematologia, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Telma F PadilhaCentro de Transplante de Medula Óssea, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Bárbara da C R Monte-MórCentro de Transplante de Medula Óssea, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Ilana ZalcbergCentro de Transplante de Medula Óssea, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Luciana M GutiyamaCentro de Transplante de Medula Óssea, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.ORCID 0000-0002-1644-8120

Funding

Conselho Nacional de Desenvolvimento Científico e TecnológicoFundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de JaneiroMinistério da Saúde
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, Acutefms-Like Tyrosine Kinase 3HumansMutationPrognosisFLT3 protein, humanfms-Like Tyrosine Kinase 3

Identifiers

PMID36727917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.